Payment overview · 2025
General Payments
$426.95
28 reported records · 8 companies
Healthcare provider profile · identity verified
Andrew John Ninichuck, M.D.
Allopathic & Osteopathic Physicians|General Practice · BONNE TERRE, MO · NPI 1609841956
Verified facts
What the public records show
CMS Open Payments records show Andrew John Ninichuck, M.D. received $426.95 in general payments during 2025 across 28 reported records.
ABBVIE INC. accounted for 35.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro, Ubrelvy.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 169 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported UBRELVY as an associated drug or biological on 299803 records involving 61203 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Ubrelvy by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 154 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 163 claims for Mounjaro by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $150.48 | 35.2% | 14 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $118.47 | 27.8% | 5 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $54.18 | 12.7% | 3 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $38.03 | 8.9% | 2 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $17.12 | 4.0% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $16.64 | 3.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.52 | 3.9% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $15.51 | 3.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $426.95 | 28 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $119.74 | 13 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $118.47 | 5 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $118.47 | 5 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $54.18 | 3 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $38.03 | 2 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $30.74 | 1 | 2025 |
Source payment records
|
|||||
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $17.12 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.64 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $16.52 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE Normalized: freestyle libre |
Device | Abbott Laboratories | $15.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 163 | exact normalized | Medicare Part D |
| UBRELVY ubrelvy |
2025 | Ubrelvy | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
169 | 27 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | UBRELVY open payments reported associated product |
CMS Open Payments — General Payments 299803 supporting records · 61203 recipient NPIs · example record 1201352530 |
Ubrelvy · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
154 | 26 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
163 | 25 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 964 | 100 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 656 | 68 |
| Furosemide | Furosemide | 627 | 114 |
| Omeprazole | Omeprazole | 602 | 104 |
| Lisinopril | Lisinopril | 577 | 118 |
| Gabapentin | Gabapentin | 549 | 93 |
| Potassium Chloride | Potassium Chloride | 549 | 103 |
| Levothyroxine Sodium | Levothyroxine Sodium | 531 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 385 | 77 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 371 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 370 | 73 |
| Atorvastatin Calcium | Atorvastatin Calcium | 367 | 77 |
| Tizanidine Hcl | Tizanidine Hcl | 358 | 64 |
| Oxycodone Hcl | Oxycodone Hcl | 322 | 30 |
| Amlodipine Besylate | Amlodipine Besylate | 312 | 66 |
| Famotidine | Famotidine | 296 | 55 |
| Metformin Hcl | Metformin Hcl | 295 | 53 |
| Carvedilol | Carvedilol | 268 | 52 |
| Fluticasone Propionate | Fluticasone Propionate | 250 | 46 |
| Alprazolam | Alprazolam | 237 | 30 |
| Buspirone Hcl | Buspirone Hcl | 234 | 36 |
| Trazodone Hcl | Trazodone Hcl | 223 | 48 |
| Vascepa | Icosapent Ethyl | 209 | 51 |
| Montelukast Sodium | Montelukast Sodium | 197 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 194 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 178 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 177 | 43 |
| Pregabalin | Pregabalin | 170 | 22 |
| Linzess | Linaclotide | 169 | 27 |
| Losartan Potassium | Losartan Potassium | 163 | 38 |
| Mounjaro | Tirzepatide | 163 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 160 | 39 |
| Jardiance | Empagliflozin | 154 | 26 |
| Ropinirole Hcl | Ropinirole Hcl | 147 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 145 | 30 |
| Simvastatin | Simvastatin | 141 | 22 |
| Azithromycin | Azithromycin | 138 | 83 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 136 | 36 |
| Doxepin Hcl | Doxepin Hcl | 135 | 23 |
| Meloxicam | Meloxicam | 130 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 23 |
| Ezetimibe | Ezetimibe | 128 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 126 | 21 |
| Celecoxib | Celecoxib | 123 | 28 |
| Clonidine Hcl | Clonidine Hcl | 123 | 36 |
| Meclizine Hcl | Meclizine Hcl | 122 | 22 |
| Carisoprodol | Carisoprodol | 119 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 116 | 23 |
| Eliquis | Apixaban | 111 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 107 | 24 |
| Fenofibrate | Fenofibrate Nanocrystallized | 106 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 103 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 103 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 96 | 19 |
| Glipizide | Glipizide | 95 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 95 | suppressed |
| Prednisone | Prednisone | 93 | 66 |
| Ozempic | Semaglutide | 91 | 20 |
| Myrbetriq | Mirabegron | 89 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 89 | 11 |
| Trintellix | Vortioxetine Hydrobromide | 88 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 86 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 84 | 11 |
| Sertraline Hcl | Sertraline Hcl | 83 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 82 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 81 | 52 |
| Baclofen | Baclofen | 81 | 16 |
| Calcitriol | Calcitriol | 78 | suppressed |
| Clonazepam | Clonazepam | 78 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 77 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 77 | 22 |
| Allopurinol | Allopurinol | 76 | 18 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 76 | suppressed |
| Nystatin | Nystatin | 76 | 24 |
| Spironolactone | Spironolactone | 76 | 16 |
| Topiramate | Topiramate | 75 | 20 |
| Lorazepam | Lorazepam | 74 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 72 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 20 |
| Cefuroxime | Cefuroxime Axetil | 69 | 55 |
| Tramadol Hcl | Tramadol Hcl | 67 | 11 |
| Ibuprofen | Ibuprofen | 66 | 14 |
| Memantine Hcl Er | Memantine Hcl | 62 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | 13 |
| Temazepam | Temazepam | 62 | suppressed |
| Bumetanide | Bumetanide | 61 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 61 | 22 |
| Donepezil Hcl | Donepezil Hcl | 60 | suppressed |
| Methocarbamol | Methocarbamol | 60 | 12 |
| Lovastatin | Lovastatin | 58 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 56 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 56 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | suppressed |
| Nitroglycerin | Nitroglycerin | 55 | 16 |
| Propranolol Hcl | Propranolol Hcl | 55 | suppressed |
| Bupropion Xl | Bupropion Hcl | 53 | 11 |
| Levofloxacin | Levofloxacin | 53 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 53 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 52 | suppressed |
| Fluconazole | Fluconazole | 52 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | suppressed |
| Risperidone | Risperidone | 51 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 49 | suppressed |
| Ondansetron Odt | Ondansetron | 49 | 15 |
| Primidone | Primidone | 49 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 18 |
| Finasteride | Finasteride | 46 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 44 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 30 |
| Aripiprazole | Aripiprazole | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | suppressed |
| Atenolol | Atenolol | 39 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 39 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 39 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 39 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 38 | suppressed |
| Roflumilast | Roflumilast | 38 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 37 | 13 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 37 | suppressed |
| Novolog Flexpen | Insulin Aspart | 37 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 36 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 35 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 35 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 35 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 34 | suppressed |
| Methylprednisolone | Methylprednisolone | 34 | 25 |
| Chlorthalidone | Chlorthalidone | 33 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Cilostazol | Cilostazol | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Diazepam | Diazepam | 30 | suppressed |
| Digoxin | Digoxin | 30 | suppressed |
| Glimepiride | Glimepiride | 30 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 14 |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Cimetidine | Cimetidine | 27 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 15 |
| Estradiol | Estradiol | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Jublia | Efinaconazole | 25 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Oxycontin | Oxycodone Hcl | 25 | suppressed |
| Progesterone | Progesterone, Micronized | 25 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 24 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 22 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 22 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 21 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Nateglinide | Nateglinide | 20 | suppressed |
| Nystop | Nystatin | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 20 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 19 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 14 |
| Ramipril | Ramipril | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 13 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 11 |
| Dutasteride | Dutasteride | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 16 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Febuxostat | Febuxostat | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 14 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Mirtazapine | Mirtazapine | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Procto-Med Hc | Hydrocortisone | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 13 | suppressed |
| Alprazolam Er | Alprazolam | 12 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 12 |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Savella | Milnacipran Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Valproic Acid | Valproic Acid | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 11 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Matzim La | Diltiazem Hcl | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Topamax | Topiramate | 11 | suppressed |
| Ubrelvy | Ubrogepant | 11 | suppressed |
| Veozah | Fezolinetant | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $426.95 · 28 records | ABBVIE INC. | CAPLYTA, Cologuard Collection Kit, FREESTYLE LIBRE, MOUNJARO, REXULTI, Senza, UBRELVY, VRAYLAR, ZENPEP, ZEPBOUND | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error